Diagnosis of acute leptospirosis

Expert Review of Anti-Infective Therapy

Volumn 9, Issue 1, 2011, Pages 111-121

  Toyokawa, Takao ^a   Ohnishi, Makoto ^a   Koizumi, Nobuo ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

culture; diagnosis; Leptospira; leptospirosis; microscopic agglutination test; PCR; serological test

Indexed keywords

ANTIBODY DETECTION; ANTIGEN DETECTION; BACTERIUM CULTURE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DISEASE COURSE; DNA DETERMINATION; EARLY DIAGNOSIS; GENE SEQUENCE; HUMAN; LABORATORY DIAGNOSIS; LABORATORY TEST; LEPTOSPIROSIS; PATHOGENESIS; PATIENT ASSESSMENT; POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY;

ACUTE DISEASE; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIOLOGICAL TECHNIQUES; CULTURE MEDIA; HUMANS; LEPTOSPIRA; LEPTOSPIROSIS; POLYMERASE CHAIN REACTION;

EID: 78650646099     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.10.151     Document Type: Review

References (151)

1. Faine S, Adler B, Bolin C, Perolat P. Leptospira and Leptospirosis, 2nd Edition. MediSci, Melbourne, Australia (1999).
2. Cerqueira GM, Picardeau M. A century of Leptospira strain typing. Infect. Genet. Evol. 9, 760-768 (2009).
3. Levett PN. Leptospirosis. Clin. Microbiol. Rev. 14, 296-326 (2001).
4. Bharti AR, Nally JE, Ricaldi JN, et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect. Dis. 3, 757-771 (2003).
5. McBride AJL, Athanazio DA, Reis MG, Ko AI. Leptospirosis. Curr. Opin. Infect. Dis. 18, 376-386 (2005).
6. Ricaldi JN, Vinetz JM. Leptospirosis in the tropics and in travelers. Curr. Infect. Dis. Rep. 8, 51-58 (2006).
7. Victoriano AFB, Smythe LD, Gloriani- Barzaga N, et al. Leptospirosis in the Asia Pacific region. BMC Infect. Dis. 9, 147 (2009).
8. World Health Organization. Human leptospirosis: guidance for diagnosis, surveillance, and control. World Health Organization, Geneva, Switzerland (2003).
9. World Health Organization. Leptospirosis worldwide, 1999. Weekly Epidemiol. Rec. 74, 237-242 (1999).
10. Hartskeerl RA. Leptospirosis: current status and future trends. Indian J. Med. Microbiol. 24, 309 (2006).
11. Ko AI, Reis MG, Dourado CM, et al. Urban epidemic of severe leptospirosis in Brazil. Lancet 354, 820-825 (1999).
12. Trevejo RT, Rigau-Perez JG, Ashford DA, et al. Epidemic leptospirosis associated with pulmonary hemorrhage-Nicaragua, 1995. J. Infect. Dis. 178, 1457-1463 (1998).
13. Sanders EJ, Rigau-Pérez JG, Smith HL, et al. Increase of leptospirosis in dengue-negative patients after a hurricane in Puerto Rico in 1996 (correction of 1966). Am. J. Trop. Med. Hyg. 61, 399-404 (1999).
14. Tangkanakul W, Tharmaphornpil P, Plikaytis BD, et al. Risk factors associated with leptospirosis in northeastern Thailand, 1998. Am. J. Trop. Med. Hyg. 63, 204-208 (2000).
15. Sharma S, Vijayachari P, Sugunan AP, Natarajaseenivasan K, Sehgal SC. Seroprevalence of leptospirosis among high-risk population of Andaman Islands, India. Am. J. Trop. Med. Hyg. 74, 278-283 (2006).
16. Bharadwaj R, Bal AM, Joshi SA, et al. An urban outbreak of leptospirosis in Mumbai, India. Jpn J. Infect. Dis. 55, 194-196 (2002).
17. Johnson MA, Smith H, Joseph P, et al. Environmental exposure and leptospirosis, Peru. Emerg. Infect. Dis. 10, 1016-1022 (2004).
18. Vinetz JM, Glass GE, Flexner CE, et al. Sporadic urban leptospirosis. Ann. Intern. Med. 125, 794-798 (1996).
19. Koizumi N, Muto M, Tanikawa T, et al. Human leptospirosis cases and the prevalence of rats harbouring Leptospira interrogans in urban areas of Tokyo, Japan. J. Med. Microbiol. 58, 1227-1230 (2009).
20. Narita M, Fujitani S, Haake DA, Paterson DL. Leptospirosis after recreational exposure to water in the Yaeyama Islands, Japan. Am. J. Trop. Med. Hyg. 73, 652-656 (2005).
21. Nakamura M, Taira K, Itokazu K, et al. Sporadic cases and an outbreak of leptospirosis probably associated with recreational activities in rivers in the northern part of Okinawa Main Island. J. Vet. Med. Sci. 68, 83-85 (2006).
22. Nardone A, Capek I, Baranton G, et al. Risk factors for leptospirosis in Metropolitan France: results of a national case-control study, 1999-2000. Clin. Infect. Dis. 39, 751-753 (2004).
23. Sejvar J, Bancroft E, Winthrop K, et al. Leptospirosis in Eco-Challenge athletes, Malaysian Borneo, 2000. Emerg. Infect. Dis. 9, 702-707 (2003).
24. Jansen A, Schöneberg I, Frank C, et al. Leptospirosis in Germany, 1962-2003. Emerg. Infect. Dis. 11, 1048-1054 (2005).
25. Pavli A , Maltezou HC. Travel-acquired leptospirosis. J. Travel Med. 15, 447-453 (2008).
26. Morgan J, Bornstein SL, Karpati AM, et al. Outbreak of leptospirosis among triathlon participants and community residents in Springfield, Illinois, 1998. Clin. Infect. Dis. 34, 1593-1599 (2002).
27. Stern EJ, Galloway, R, Shadomy, SV, et al. Outbreak of leptospirosis among Adventure Race participants in Florida, 2005. Clin. Infect. Dis. 50, 843-849 (2010).
28. Brockmann S, Piechotowski I, Bock-Hensley O, et al. Outbreak of leptospirosis among triathlon participants in Germany, 2006. BMC Infect. Dis. 10, 91 (2010).
29. Ashford DA, Kaiser RM, Spiegel RA, et al. Asymptomatic infection and risk factors for leptospirosis in Nicaragua. Am. J. Trop. Med. Hyg. 63, 249-254 (2000).
30. Bovet P, Yersin C, Merien F, Davis CE, Perolat P. Factors associated with clinical leptospirosis: a population-based case- control study in the Seychelles (Indian Ocean). Int. J. Epidemiol. 28, 583-590 (1999).
31. Levett PN. Leptospirosis. In: Principles and Practice of Infectious Diseases. 7th Edition. Mandell GL, Bennet JE, Dolin R (Eds). Churchill Livingstone, Philadelphia, PA, USA, 3059-3065 (2010).
32. Farr RW. Leptospirosis. Clin. Infect. Dis. 21, 1-6 (1995).
33. Visith S, Kearkiat P. Nephropathy in leptospirosis. J. Postgrad. Med. 51, 184-188 (2005).
34. Daher E, Zanetta DM, Cavalcante MB, Abdulkader RC. Risk factors for death and changing pattern in leptospirosis acute renal failure. Am. J. Trop. Med. Hyg. 61, 630-634 (1999).
35. Edwards CN, Nicholson GD, Hassel TA, Everard COR, Callender J. Thrombocytopenia in leptospirosis: the absence of evidence for disseminated intravascular coagulation. Am. J. Trop. Med. Hyg. 35, 352-354 (1986).
36. Nicodemo AC, Duarte MIS, Alves DVAF, et al. Lung lesions in human leptospirosis: microscopic, immunohistochemical, and ultrastructural features related to thrombocytopenia. Am. J. Trop. Med. Hyg. 56, 181-187 (1997).
37. Segura ER, Ganoza CA, Campos K, et al. Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden. Clin. Infect. Dis. 40, 343-351 (2005).
38. Dolhnikoff M, Mauad T, Bethlem EP, Carvalho CRR. Leptospiral pneumonias. Curr. Opin. Pulm. Med. 13, 230-235 (2007).
39. Gouveia EL, Metcalfe J, de Carvalho ALF, et al. Leptospirosis-associated severe pulmonary hemorrhagic Syndrome, Salvador, Brazil. Emerg. Infect. Dis. 14, 505-508 (2008).
40. Sasaki DM, Pang L, Minette HP, et al. Active surveillance and risk factors for leptospirosis in Hawaii. Am. J. Trop. Med. Hyg. 48, 35-43 (1993).
41. Bal AM. Unusual clinical manifestations of leptospirosis. J. Postgrad. Med. 51, 179-183 (2005).
42. Wongsrichanalai C, Murray CK, Gray M, et al. Co-infection with malaria and leptospirosis. Am. J. Trop. Med. Hyg. 68, 583-585 (2003).
43. Suputtamongkol Y, Niwattayakul K, Suttinont C, et al. An open, randomized, controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis. Clin. Infect. Dis. 39, 1417-1424 (2004).
44. LaRocque RC, Breiman RF, Ari MD, et al. Leptospirosis during dengue outbreak, Bangladesh. Emerg. Infect. Dis. 11, 766-769 (2005).
45. Ellis T, Imrie A, Katz AR, Effler PV. Underrecognition of leptospirosis during dengue fever outbreak in Hawaii, 2001-2002. Vector Borne Zoonotic Dis. 8, 541-547 (2008).
46. Brown MG, Vickers IE, Salas RA, Smikle MF. Leptospirosis in suspected cases of dengue in Jamaica, 2002-2007. Trop. Doct. 40, 92-94 (2010).
47. Zaki SA, Shanbag P. Clinical manifestations of dengue and leptospirosis in children in Mumbai: an observational study. Infection 38, 285-291 (2010).
48. Faine S. The acute infection in man. In: Guidelines for the Control of Leptospirosis. World Health Organisation, Geneva, Switzerland, 43-54 (1982).
49. Kuriakose M, Eapen CK, Punnoose E, Koshi G. Leptospirosis - clinical spectrum and correlation with severe simple laboratory tests for the early diagnosis in the third world. Trans. R. Soc. Trop. Med. Hyg. 84, 419-421 (1990).
50. Sehgal SC. Recommendations of national symposium on leptospirosis. Indian J. Med. Microbiol. 15, 211-212 (1997).
51. Bal AM, Kakrani AL, Bharadwaj RS, et al. Evaluation of clinical criteria for the diagnosis of leptospirosis. J. Assoc. Physicians India 50, 394-396 (2002).
52. Shivakumar S, Shareek PS. Diagnosis of leptospirosis utilizing modified Faines criteria. J. Assoc. Physicians India 52, 678-679 (2004).
53. Dupont H, Dupont-Perdrizet D, Perie JL, et al. Leptospirosis: prognostic factors associated with mortality. Clin. Infect. Dis. 25, 720-724 (1997).
54. Daher E, Zanetta DMT, Cavalcante MB, Abdulkader RCRM. Risk factors for death and changing patterns in leptospirosis acute renal failure. Am. J. Trop. Med. Hyg. 61, 630-634 (1999).
55. Panaphut T, Domrongkitchaiporn S, Thinkamrop B. Prognostic factors of death in leptospirosis: a prospective cohort study in Khon Kaen, Thailand. Int. J. Infect. Dis. 6, 525-529 (2002).
56. Esen S, Sunbul M, Leblebicioglu H, Eroglu C, Turan D. Impact of clinical and laboratory findings on prognosis in leptospirosis. Swiss Med. Wkly 134, 347-352 (2004).
57. Paganin F, Bourdin A, Dalban C, et al. Leptospirosis in Reunion Island (Indian Ocean): analysis of factors associated with severity in 147 confirmed cases. Intensive Care Med. 33, 1959-1966 (2007).
58. Spichler AS, Vilaca PJ, Athanazio DA, et al. Predictors of lethality in severe leptospirosis in urban Brazil. Am. J. Trop. Med. Hyg. 79, 911-914 (2008).
59. Marotto PCF, Ko AI, Murta-Nascimento C, et al. Early identification of leptospirosis-associated pulmonary hemorrhage syndrome by use of a validated prediction model. J. Infect. 60, 218-223 (2010).
60. Saengjaruk P, Chaicumpa W, Watt G, et al. Diagnosis of human leptospirosis by monoclonal antibody-based antigen detection in urine. J. Clin. Microbiol. 40, 480-489 (2002).
61. Sharma R, Tuteja U, Khushiramani R, Shukla J, Batra HV. Application of monoclonal antibodies in a rapid sandwich dot-enzyme linked immunosorbent assay for identification and antigen detection of Leptospira serovars. Hybridoma 27, 113-121 (2008).
62. Wuthiekanun V, Chierakul W, Limmathurotsakul D, et al. Optimization of culture of Leptospira from humans with leptospirosis. J. Clin. Microbiol. 45, 1363-1365 (2007).
63. Griffith ME, Horvath LL, Mika WV, et al. Viability of Leptospira in BacT/ALERT MB media. Diagn. Microbiol. Infect. Dis. 54, 263-266 (2006).
64. Levett PN. Usefulness of serologic analysis as a predictor of the infecting serovar in patients with severe leptospirosis. Clin. Infect. Dis. 36, 447-452 (2003).
65. Katz AR, Effler PV, Ansdell VE. Comparison of serology and isolates for the identification of infecting leptospiral serogroups in Hawaii, 1979-1998. Trop. Med. Int. Health 8, 639-642 (2003).
66. Smythe LD, Wuthiekanun V, Chierakul W, et al. The microscopic agglutination test (MAT) is an unreliable predictor of infecting Leptospira serovar in Thailand. Am. J. Trop. Med. Hyg. 81, 695-697 (2009).
67. Chappel RJ, Goris M, Palmer MF, Hartskeerl RA. Impact of proficiency testing on results of the microscopic agglutination test for diagnosis of leptospirosis. J. Clin. Microbiol. 42, 5484-5488 (2004).
68. Smits HL, Eapen CK, Sheela Sugathan S, et al. Lateral-flow assay for rapid serodiagnosis of human leptospirosis. Clin. Diagn. Lab. Immunol. 8, 166-169 (2001).
69. Gussenhoven GC, van der Hoorn MA, Goris MG, et al. LEPTO dipstick, a dipstick assay for detection of Leptospira-specific immunoglobulin M antibodies in human sera. J. Clin. Microbiol. 35, 92-97 (1997).
70. Winslow WE, Merry DJ, Pirc ML, Devine PL. Evaluation of a commercial enzyme-linked immunosorbent assay for detection of immunoglobulin M antibody in diagnosis of human leptospiral infection. J. Clin. Microbiol. 35, 1938-1942 (1997).
71. Levett PN, Whittington CU. Evaluation of the indirect hemagglutination assay for diagnosis of acute leptospirosis. J. Clin. Microbiol. 36, 11-14 (1998).
72. Smits HL, van der Hoorn MA, Goris MG, et al. Simple latex agglutination assay for rapid serodiagnosis of human leptospirosis. J. Clin. Microbiol. 38, 1272-1275 (2000).
73. Addamiano L, Babudieri B. Water strains of Leptospira in the serodiagnosis of human and animal leptospirosis. Bull. World Health Organ. 39, 925-934 (1968).
74. Turner LH. Leptospirosis. II. Serology. Trans. R. Soc. Trop. Med. Hyg. 62, 880-899 (1968).
75. Matsuo K, Isogai E, Araki Y. Occurrence of [3)-b-d-Manp-(1-4)-b-d-Manp- (1] n units in the antigenic polysaccharides from Leptospira biflexa serovar patoc strain Patoc I. Carbohydr. Res. 328, 517-524 (2000).
76. Smits HL, Ananyina YV, Chereshsky A, et al. International multicenter evaluation of the clinical utility of a dipstick assay for detection of Leptospira-specific immunoglobulin M antibodies in human serum specimens. J. Clin. Microbiol. 37, 2904-2909 (1999).
77. Smits HL, Hartskeerl RA, Terpstra WJ. International multi-centre evaluation of a dipstick assay for human leptospirosis. Trop. Med. Int. Health 5, 124-128 (2000).
78. Smits HL, Chee HD, Eapen CK, et al. Latex based, rapid and easy assay for human leptospirosis in a single test format. Trop. Med. Int. Health 6, 114-118 (2001).
79. Effler PV, Bogard AK, Domen HY, et al. Evaluation of eight rapid screening tests for acute leptospirosis in Hawaii. J. Clin. Microbiol. 40, 1464-1469 (2002).
80. Levett PN, Branch SL. Evaluation of two enzyme-linked immunosorbent assay methods for detection of immunoglobulin M antibodies in acute leptospirosis. Am. J. Trop. Med. Hyg. 66, 745-748 (2002).
81. Vijayachari P, Sugunan AP, Sehgal SC. Evaluation of Lepto Dri Dot as a rapid test for the diagnosis of leptospirosis. Epidemiol. Infect. 129, 617-621 (2002).
82. Bajani MD, Ashford DA, Bragg SL, et al. Evaluation of four commercially available rapid serologic tests for diagnosis of leptospirosis. J. Clin. Microbiol. 41, 803-809 (2003).
83. Sehgal SC, Vijayachari P, Sugunan AP, Umapathi T. Field application of Lepto lateral flow for rapid diagnosis of leptospirosis. J. Med. Microbiol. 52, 897-901 (2003).
84. Hull-Jackson C, Glass MB, Ari MD, et al. Evaluation of a commercial latex agglutination assay for serological diagnosis of leptospirosis. J. Clin. Microbiol. 44, 1853-1855 (2006).
85. McBride AJA, Santos BL, Queiroz A, et al. Evaluation of four whole-cell Leptospira-based serological tests for diagnosis of urban leptospirosis. Clin. Vaccine Immunol. 14, 1245-1248 (2007).
86. Blacksell SD, Smythe L, Phetsouvanh R, et al. Limited diagnostic capacities of two commercial assays for the detection of Leptospira immunoglobulin M antibodies in Laos. Clin. Vac. Immunol. 13, 1166-1169 (2006).
87. Myint KS, Gibbons RV, Murray CK, et al. Leptospirosis in Kamphaeng Phet, Thailand. Am. J. Trop. Med. Hyg. 76, 135-138 (2007).
88. Guerreiro H, Croda J, Flannery B, et al. Leptospiral proteins recognized during the humoral immune response to leptospirosis in humans. Infect. Immun. 69, 4958-4968 (2001).
89. Doungchawee G, Kositanont U, Niwetpathomwat A, et al. Early diagnosis of leptospirosis by immunoglobulin M immunoblot testing. Clin. Vac. Immunol. 15, 492-498 (2008).
90. Koizumi K, Watanabe H. Leptospirosis. In: Vaccines for Biodefense and Emerging and Neglected Diseases. Barrett ADT, Stanberry LR (Ed.). Academic Press, London, UK, 1291-1308 (2009).
91. Flannery B, Costa D, Carvalho FP, et al. Evaluation of recombinant Leptospira antigen-based enzyme-linked immunosorbent assays for the serodiagnosis of leptospirosis. J. Clin. Microbiol. 39, 3303-3310 (2001).
92. Luo D, Xue F, Ojcius DM, et al. Protein typing of major outer membrane lipoproteins from Chinese pathogenic Leptospira spp. and characterization of their immunogenicity. Vaccine 28, 243-242 (2010).
93. Natarajaseenivasan K, Vijayachari P, Sharma S, et al. Serodiagnosis of severe leptospirosis: evaluation of ELISA based on the recombinant OmpL1 or LipL41 antigens of Leptospira interrogans serovar autumnalis. Ann. Trop. Med. Parasitol. 102, 699-708 (2008).
94. Dong H, Hu Y, Xue F, et al. Characterization of the ompL1 gene of pathogenic Leptospira species in China and cross-immunogenicity of the OmpL1 protein. BMC Microbiol. 8, 223 (2008).
95. Matsunaga J, Barocchi MA, Croda J, et al. Pathogenic Leptospira species express surface-exposed proteins belonging to the bacterial immunoglobulin superfamily. Mol. Microbiol. 49, 929-945 (2003).
96. Koizumi N, Watanabe H. Leptospiral immunoglobulin-like proteins elicit protective immunity. Vaccine 22, 1545-1552 (2004).
97. Choy HA, Kelley MM, Chen TL, et al. Physiological osmotic induction of Leptospira interrogans adhesion: LigA and LigB bind extracellular matrix proteins and fibrinogen. Infect. Immun. 75, 2441-2450 (2007).
98. Silva EF, Medeiros MA, McBride AJ, et al. The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine 25, 6277-6286 (2007).
99. Lin YP, Lee DW, McDonough SP, et al. Repeated domains of Leptospira immunoglobulin-like proteins interact with elastin and tropoelastin. J. Biol. Chem. 284, 19380-19391 (2009).
100. Croda J, Ramos JGR, Matsunaga J, et al. Leptospira immunoglobulin-like proteins as a serodiagnostic marker for acute leptospirosis. J. Clin. Microbiol. 45, 1528-1534 (2007).
101. Neves FO, Abreu PA, Vasconcellos SA, et al. Identification of a novel potential antigen for early-phase serodiagnosis of leptospirosis. Arch. Microbiol. 188, 523-532 (2007).
102. Oliveira TR, Longhi MT, de Morais ZM, et al. Evaluation of leptospiral recombinant antigens MPL17 and MPL21 for serological diagnosis of leptospirosis by enzyme-linked immunosorbent assays. Clin. Vac. Immunol. 15, 1715-1722 (2008).
103. Senthilkumar TMA, Subathra M, Phil M, Ramadass P, Ramaswamy V. Rapid serodiagnosis of leptospirosis by latex agglutination test and flow-through assay. Indian J. Med. Microbiol. 26, 45-49 (2008).
104. Boonyod D, Poovorawan Y, Bhattarakosol P, Chirathaworn C. LipL32, an outer membrane protein of Leptospira, as an antigen in a dipstick assay for diagnosis of leptospirosis. Asian Pac. J. Allergy Immunol. 23, 133-141 (2005).
105. Merien F, Baranton G, Perolat P. Comparison of polymerase chain reaction with microagglutination test and culture for diagnosis of leptospirosis. J. Infect. Dis. 172, 281-285 (1995).
106. Brown PD, Gravekamp C, Carrington DG, et al. Evaluation of the polymerase chain reaction for early diagnosis of leptospirosis. J. Med. Microbiol. 43, 110-114 (1995).
107. Koizumi N, Watanabe H, Umezawa K, Iiduka T, Inokuchi S. A case of leptospirosis diagnosed early by flaB-PCR. Kansenshogaku Zasshi. 77, 627-630 (2003).
108. Fonseca CA, Teixeira MMG, Romero EC, et al. Leptospira DNA detection for the diagnosis of human leptospirosis. J. Infect. 52, 15-22 (2006).
109. Fonseca CA, de Freitas VLT, Romero EC, et al. Polymerase chain reaction in comparison with serological tests for early diagnosis of human leptospirosis. Trop. Med. Int. Health 11, 1699-1707 (2006).
110. Kositanont U, Rugsasuk S, Leelaporn A, et al. Detection and differentiation between pathogenic and saprophytic Leptospira spp. by multiplex polymerase chain reaction. Diagn. Microbiol. Infect. Dis. 57, 117-122 (2007).
111. Brown PD, Carrington DG, Gravekamp C, et al. Direct detection of leptospiral material in human postmortem samples. Res. Microbiol. 154, 581-586 (2003).
112. Smythe LD, Smith IL, Smith GA, et al. A quantitative PCR (TaqMan) assay for pathogenic Leptospira spp. BMC Infect. Dis. 2, 13 (2002).
113. Palaniappan RU, Chang YF, Chang CF, et al. Evaluation of lig-based conventional and real time PCR for the detection of pathogenic leptospires. Mol. Cell. Probes 19, 111-117 (2005).
114. Merien F, Portnoi D, Bourhy P, et al. A rapid and quantitative method for the detection of Leptospira species in human leptospirosis. FEMS Microbiol. Lett. 249, 139-147 (2005).
115. Levett PN, Morey RE, Galloway RL, et al. Detection of pathogenic leptospires by real-time quantitative PCR. J. Med. Microbiol. 54, 45-49 (2005).
116. Slack AT, Symonds ML, Dohnt MF, Smythe LD. Identification of pathogenic Leptospira species by conventional or real-time PCR and sequencing of the DNA gyrase subunit B encoding gene. BMC Microbiol. 6, 95 (2006).
117. Slack A, Symonds M, Dohnt M, et al. Evaluation of a modified Taqman assay detecting pathogenic Leptospira spp. against culture and Leptospira-specific IgM enzyme-linked immunosorbent assay in a clinical environment. Diagn. Microbiol. Infect. Dis. 57, 361-366 (2007).
118. Stoddard RA, Gee JE, Wilkins PP, McCaustland K, Hoffmaster AR. Detection of pathogenic Leptospira spp. through TaqMan polymerase chain reaction targeting the LipL32 gene. Diagn. Microbiol. Infect. Dis. 64, 247-255 (2009).
119. Ahmed A, Engelberts MFM, Boer KR, Ahmed N, Hartskeerl RA. Development and validation of a real-time PCR for detection of pathogenic Leptospira species in clinical materials. PLoS ONE 4, e7093 (2009).
120. Lourdault K, Aviat F, Picardeau M. Use of quantitative real-time PCR for studying the dissemination of Leptospira interrogans in the guinea pig infection model of leptospirosis. J. Med. Microbiol. 58, 648-655 (2009).
121. Lin X, Chen Y, Lu Y, Yan J, Yan J. Application of a loop-mediated isothermal amplification method for the detection of pathogenic Leptospira. Diagn. Microbiol. Infect. Dis. 63, 237-242 (2009).
122. Mori Y, Notomi T. Loop-mediated isothermal amplification (LAMP): a rapid, accurate, and cost-effective diagnostic method for infectious diseases. J. Infect. Chemother. 15, 62-69 (2009).
123. Ganoza CA, Matthias MA, Saito M, et al. Asymptomatic renal colonization of humans in the peruvian Amazon by Leptospira. PLoS Negl. Trop. Dis. 4, e612 (2010).
124. Suputtamongkol Y, Pongtavornpinyo W, Lubell Y, et al. Strategies for diagnosis and treatment of suspected leptospirosis: a cost-benefit analysis. PLoS Negl. Trop. Dis. 4, e610 (2010).
125. Hoorfar J, Wolffs P, Rådström P. Diagnostic PCR: validation and sample preparation are two sides of the same coin. APMIS 112, 808-814 (2004).
126. Klugman KP, Madhi SA, Albrich WC. Novel approaches to the identification of Streptococcus pneumoniae as the cause of community-acquired pneumonia. Clin. Infect. Dis. 47, S202-S206 (2008).
127. Shimada T, Noguchi Y, Jackson JL, et al. Systematic review and metaanalysis: urinary antigen tests for legionellosis. Chest 136, 1576-1585 (2009).
128. Ren SX, Fu G, Jiang XG, et al. Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing. Nature 422, 888-893 (2003).
129. Nascimento AL, Ko AI, Martins EA, et al. Comparative genomics of two Leptospira interrogans serovars reveals novel insights into physiology and pathogenesis. J. Bacteriol. 186, 2164-2172 (2004).
130. Bulach DM, Zuerner RL, Wilson P, et al. Genome reduction in Leptospira borgpetersenii reflects limited transmission potential. Proc. Natl Acad. Sci. USA 103, 14560-14565 (2006).
131. Picardeau M, Bulach DM, Bouchier C, et al. Genome sequence of the saprophyte Leptospira biflexa provides insights into the evolution of Leptospira and the pathogenesis of leptospirosis. PLoS ONE 3, e1607 (2008).
132. Gamberini M, Gomez RM, Atzingen MV, et al. Whole-genome analysis of Leptospira interrogans to identify potential vaccine candidates against leptospirosis. FEMS Microbiol. Lett. 244, 305-313 (2005).
133. Viratyosin W, Ingsriswang S, Pacharawongsakda E, Palittapongarnpim P. Genome-wide subcellular localization of putative outer membrane and extracellular proteins in Leptospira interrogans serovar Lai genome using bioinformatics approaches. BMC Genomics 9, 181 (2008).
134. Yang HL, Zhu YZ, Qin JH, et al. In silico and microarray-based genomic approaches to identifying potential vaccine candidates against Leptospira interrogans. BMC Genomics 7, 293 (2006).
135. Qin JH, Sheng YY, Zhang ZM, et al. Genome-wide transcriptional analysis of temperature shift in L. interrogans serovar Lai strain 56601. BMC Microbiol. 6, 51 (2006).
136. Lo M, Bulach DM, Powell DR, et al. Effects of temperature on gene expression patterns in Leptospira interrogans serovar Lai as assessed by whole-genome microarrays. Infect. Immun. 74, 5848-5859 (2006).
137. Matsunaga J, Lo M, Bulach DM, et al. Response of Leptospira interrogans to physiologic osmolarity: relevance in signaling the environment-to-host transition. Infect. Immun. 75, 2864-2874 (2007).
138. Patarakul K, Lo M, Adler B. Global transcriptomic response of Leptospira interrogans serovar Copenhageni upon exposure to serum. BMC Microbiol. 10, 31 (2010).
139. Lo M, Murray GL, Khoo CA, et al. Transcriptional response of Leptospira interrogans to iron limitation and characterization of a PerR homolog. Infect. Immun. DOI:10.1128/IAI.00435-00410 (2010) (Epub ahead of print).
140. Thongboonkerd V. Proteomics in leptospirosis research: towards molecular diagnostics and vaccine development. Expert Rev. Mol. Diagn. 8, 53-61 (2008).
141. Ko AI, Goarant C, Picardeau M. Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen. Nat. Rev. Microbiol. 7, 736-747 (2009).
142. Bourhy P, Louvel H, Saint Girons I, Pacardeau M. Random insertional mutagenesis of Leptospira interrogans, the agent of leptospirosis, using a mariner transposon. J. Bacteriol. 187, 3255-3258 (2005).
143. Murray GL, Morel V, Cerqueira GM, et al. Genome-wide transposon mutagenesis in pathogenic Leptospira species. Infect. Immun. 77, 810-816 (2009).
144. Berman SJ, Tsai CC, Holmes K, Fresh JW, Watten RH. Sporadic anicteric leptospirosis in South Vietnam. a study in 150 patients. Ann. Intern. Med. 79, 167-173 (1973).
145. Park SK, Lee SH, Rhee YK, et al. Leptospirosis in Chonbuk Province of Korea in 1987: a Study of 93 Patients. Am. J. Trop. Med. Hyg. 41, 345-351 (1989).
146. Edwards CN, Nicholson GD, Hassell TA, Everard CO, Callender J. Leptospirosis in Barbados. a clinical study. West Indian Med. J. 39, 27-34 (1990).
147. Kishaba T. Leptospirosis. In: Integrated Handbook of Internal Medicine Volume 28. Saito A, Shimada K (Eds). Nakayama- Shoten, Tokyo, Japan, 146-154 (1994) (In Japanese).
148. Yersin C, Bovet P, Mérien F, et al. Human leptospirosis in the Seychelles (Indian Ocean). A population-based study. Am. J. Trop. Med. Hyg. 59, 933-940 (1998).
149. Katz AR, Ansdell VE, Effler PV, Middleton CR, Sasaki DM. Assessment of the clinical presentation and treatment of 353 cases of laboratory-confirmed leptospirosis in Hawaii, 1974-1998. Clin. Infect. Dis. 33, 1834-1841 (2001).
150. Daher EF, Lima RS, Silva Júnior GB, et al. Clinical presentation of leptospirosis: a retrospective study of 201 patients in a metropolitan city of Brazil. Braz. J. Infect. Dis. 14, 3-10 (2010).
151. Leptospirosis - Philippines: (METRO MANILA, RIZAL) http://promedmail.org/ pls/otn/f?p=2400:1001:3251010479785508::: :F2400-P1001-BACK-pagE,F2400- P1001-ARCHIVE-NUMBER,F2400- P1001-USE-ARCHIVE:1001,20091016. 3561,Y (Accessed 12 September 2010)